Xu et al. demonstrated that RUNX1 plays an oncogenic role in GBM, and that RUNX1 induces temozolomide resistance in GBM by up-regulating MRP1, which is negatively regulated by miR-128-3p [50]. Here, RUNX1 is linked to glioblastoma.